ARIX.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 feb 2024 @ 18:15):

Stats
Dagens volum	13.86M
Gjennomsnittsvolum	462 154
Markedsverdi	183.73M
EPS	£0 ( 2024-04-22 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	12.91
ATR14	£2.89 (2.03%)

Volum Korrelasjon

Lang: 0.24 (neutral)

Kort: -0.87 (strong negative)

Signal:(69.448) Neutral

Arix Bioscience PLC Korrelasjon

10 Mest positive korrelasjoner
JUSC.L	0.918
FLO.L	0.886
ADVT.L	0.871
EPWN.L	0.863
ALU.L	0.842
ATS.L	0.836
AHT.L	0.832
MTR.L	0.831
SLI.L	0.829
TBCG.L	0.828

10 Mest negative korrelasjoner
TRS3.L	-0.842
MDBG.L	-0.819
PHPM.L	-0.815
DDBG.L	-0.806

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Arix Bioscience PLC Korrelasjon - Valuta/Råvare

0.42
( neutral )

0.84
( strong )

0.39
( neutral )

0.66
( moderate )

-0.85
( strong negative )

-0.39
( neutral )

Arix Bioscience PLC Økonomi

Annual	2022
Omsetning:	£112 000
Bruttogevinst:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2022
Omsetning:	£112 000
Bruttogevinst:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2021
Omsetning:	£340 000
Bruttogevinst:	£0.00 (0.00 %)
EPS:	£-0.582

FY	2020
Omsetning:	£477 000
Bruttogevinst:	£0.00 (0.00 %)
EPS:	£0.968

Financial Reports:

No articles found.

Arix Bioscience PLC

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.